These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17540195)

  • 1. Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.
    Sanders GD; Al-Khatib SM; Berliner E; Bigger JT; Buxton AE; Califf RM; Carlson M; Curtis AB; Curtis JP; Domanski M; Fain E; Gersh BJ; Gold MR; Goldberger J; Haghighi-Mood A; Hammill SC; Harder J; Healey J; Hlatky MA; Hohnloser SH; Lee KL; Mark DB; Mitchell B; Phurrough S; Prystowsky E; Smith JM; Stockbridge N; Temple R;
    Am Heart J; 2007 Jun; 153(6):951-9. PubMed ID: 17540195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death.
    Al-Khatib SM; Sanders GD; Bigger JT; Buxton AE; Califf RM; Carlson M; Curtis A; Curtis J; Fain E; Gersh BJ; Gold MR; Haghighi-Mood A; Hammill SC; Healey J; Hlatky M; Hohnloser S; Kim RJ; Lee K; Mark D; Mianulli M; Mitchell B; Prystowsky EN; Smith J; Steinhaus D; Zareba W;
    Am Heart J; 2007 Jun; 153(6):941-50. PubMed ID: 17540194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention.
    Al-Khatib SM; Sanders GD; Carlson M; Cicic A; Curtis A; Fonarow GC; Groeneveld PW; Hayes D; Heidenreich P; Mark D; Peterson E; Prystowsky EN; Sager P; Salive ME; Thomas K; Yancy CW; Zareba W; Zipes D
    Am Heart J; 2008 Oct; 156(4):613-22. PubMed ID: 18926144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
    Al-Khatib SM; Sanders GD; Mark DB; Lee KL; Bardy GH; Bigger JT; Buxton AE; Connolly S; Kadish A; Moss A; Feldman AM; Ellenbogen KA; Singh S; Califf RM;
    Am Heart J; 2005 Jun; 149(6):1020-34. PubMed ID: 15976783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice.
    Eapen ZJ; Peterson ED; Fonarow GC; Sanders GD; Yancy CW; Sears SF; Carlson MD; Curtis AB; Hall LL; Hayes DL; Hernandez AF; Mirro M; Prystowsky E; Russo AM; Thomas KL; Al-Khatib SM
    Am Heart J; 2011 Aug; 162(2):222-31. PubMed ID: 21835281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Sudden Cardiac Death in Adults With Congenital Heart Disease: Do the Guidelines Fall Short?
    Vehmeijer JT; Koyak Z; Budts W; Harris L; Silversides CK; Oechslin EN; Bouma BJ; Zwinderman AH; Mulder BJM; de Groot JR
    Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28696220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden cardiac death: epidemiologic and financial worldwide perspective.
    Smith TW; Cain ME
    J Interv Card Electrophysiol; 2006 Dec; 17(3):199-203. PubMed ID: 17333367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.
    Anderson KP
    J Interv Card Electrophysiol; 2005 Nov; 14(2):71-8. PubMed ID: 16374553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death in China: current status and future perspectives.
    Zhang S
    Europace; 2015 Oct; 17 Suppl 2():ii14-8. PubMed ID: 26842111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection].
    Neuzner J; Gradaus R
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):75-81. PubMed ID: 26041117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
    Saba S
    Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging for assessment of sudden death risk: current role and future prospects.
    Suzuki T; Nazarian S; Jerosch-Herold M; Chugh SS
    Europace; 2016 Oct; 18(10):1491-1500. PubMed ID: 27098112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.